Synthetic and Systems Biotechnology (Sep 2016)

Discovery of tanshinone derivatives with anti-MRSA activity via targeted bio-transformation

  • Wenni He,
  • Miaomiao Liu,
  • Pei Huang,
  • Wael M. Abdel-Mageed,
  • Jianying Han,
  • Jeramie D. Watrous,
  • Don D. Nguyen,
  • Wenzhao Wang,
  • Fuhang Song,
  • Huanqin Dai,
  • Jingyu Zhang,
  • Ronald J. Quinn,
  • Tanja Grkovi,
  • Houwei Luo,
  • Lixin Zhang,
  • Xueting Liu

DOI
https://doi.org/10.1016/j.synbio.2016.05.002
Journal volume & issue
Vol. 1, no. 3
pp. 187 – 194

Abstract

Read online

Two potent anti-MRSA tanshinone glycosides (1 and 2) were discovered by targeted microbial biotransformation, along with rapid identification via MS/MS networking. Serial reactions including dehydrogenation, demethylations, reduction, glycosylation and methylation have been observed after incubation of tanshinone IIA and fungus Mucor rouxianus AS 3.3447. In addition, tanshinosides B (2) showed potent activities against serial clinical isolates of oxacillin-resistant Staphylococcus aureus with MIC values of 0.78 μg/mL. This is the first study that shows a significant increase in the level and activities of tanshinone glycosides relative to the substrate tanshinone IIA.

Keywords